DK0608568T3 - Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler - Google Patents

Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler

Info

Publication number
DK0608568T3
DK0608568T3 DK93121091T DK93121091T DK0608568T3 DK 0608568 T3 DK0608568 T3 DK 0608568T3 DK 93121091 T DK93121091 T DK 93121091T DK 93121091 T DK93121091 T DK 93121091T DK 0608568 T3 DK0608568 T3 DK 0608568T3
Authority
DK
Denmark
Prior art keywords
beta
aminocycloalkanobenzodioxols
adrenergic agents
selective adrenergic
selective
Prior art date
Application number
DK93121091T
Other languages
English (en)
Inventor
Joseph William Epstein
Minu Dhanjisha Dutia
Gary Harold Birnberg
Gary Edward Walker
Jonathan David Bloom
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0608568T3 publication Critical patent/DK0608568T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK93121091T 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler DK0608568T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1097393A 1993-01-29 1993-01-29

Publications (1)

Publication Number Publication Date
DK0608568T3 true DK0608568T3 (da) 1998-09-28

Family

ID=21748304

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93121091T DK0608568T3 (da) 1993-01-29 1993-12-30 Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler

Country Status (10)

Country Link
US (2) US5510376A (da)
EP (1) EP0608568B1 (da)
JP (1) JPH072831A (da)
KR (1) KR940018376A (da)
AT (1) ATE163930T1 (da)
CA (1) CA2114359A1 (da)
DE (1) DE69317399T2 (da)
DK (1) DK0608568T3 (da)
ES (1) ES2115003T3 (da)
SG (1) SG47557A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
KR100490003B1 (ko) * 1995-05-12 2005-12-21 닛신 파마 가부시키가이샤 1,4-벤조디옥신유도체
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
EP1070046A1 (en) 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2010050445A1 (ja) * 2008-10-27 2010-05-06 武田薬品工業株式会社 二環性化合物
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles

Also Published As

Publication number Publication date
US5594027A (en) 1997-01-14
KR940018376A (ko) 1994-08-16
CA2114359A1 (en) 1994-07-30
DE69317399T2 (de) 1998-07-02
US5510376A (en) 1996-04-23
ATE163930T1 (de) 1998-03-15
DE69317399D1 (de) 1998-04-16
EP0608568A1 (en) 1994-08-03
ES2115003T3 (es) 1998-06-16
JPH072831A (ja) 1995-01-06
EP0608568B1 (en) 1998-03-11
SG47557A1 (en) 1998-04-17

Similar Documents

Publication Publication Date Title
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DK0608568T3 (da) Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
DK0707007T3 (da) Amino(thio)etherderivater som CNS-aktive midler
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
NO920767D0 (no) Pyranylcyanoguanidin-derivater
DK0984778T3 (da) Neuropeptid-Y-ligander
FI901956A7 (fi) Uusia naftalenyylialkyyli-3H-1,2,3,5-oksatiadiatsoli-2-oksideja, jotka ovat käyttökelpoisia antihyperglykeemisinä aineina
NO995963D0 (no) Karboksamider anvendelige som 5-HTIF-agonister
PT99503A (pt) Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem
ES2094136T3 (es) Intermediarios quirales de 1,5-diyodo-2-metoxi o benciloxi.
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
ATE250021T1 (de) Hydroxycyclopentanone
DK0566175T3 (da) 3,4-diaryl-(5H)-furan-2-on-baserede forbindelser med fungicid aktivitet
AR009452A1 (es) Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ITMI930819A1 (it) Derivati eterobiciclici ad attivita' fungicida
DK0381989T3 (da) 4-epi-4-amino-anthracycliner
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
BR9507857A (pt) Um processo para a preparação de derivados de 5,6-Diidroxi-2-amino-1,2,3,4-tetraidronaftaleno
PT882045E (pt) Processo para a preparacao de granisetron
ITMI920228A1 (it) Tiazolilpirroli ad attivita' fungicida
ATE100996T1 (de) Blattglanzmittel.
PT89130A (pt) Processo para a preparacao de novos compostos de azol